Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Edmonton Dyspnea Inventory (EDI) in Interstitial Lung Diseases: Understanding Dyspnea Severity and Impact of EDI Use in Individuals With Interstitial Lung Disease

NCT06290635 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06290635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Edmonton Dyspnea Inventory (EDI) in Interstitial Lung Diseases: Understanding Dyspnea Severity and Impact of EDI Use in Individuals With Interstitial Lung Disease
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Completed
Start date
November 11, 2022
Completion date
January 31, 2025
Enrollment
79 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ild